55 related articles for article (PubMed ID: 36093688)
21. An AI-Ready Multiplex Staining Dataset for Reproducible and Accurate Characterization of Tumor Immune Microenvironment.
Ghahremani P; Marino J; Hernandez-Prera J; de la Iglesia JV; Slebos RJ; Chung CH; Nadeem S
ArXiv; 2023 May; ():. PubMed ID: 37292462
[TBL] [Abstract][Full Text] [Related]
22. Single-cell transcriptomic analysis of mIHC images via antigen mapping.
Govek KW; Troisi EC; Miao Z; Aubin RG; Woodhouse S; Camara PG
Sci Adv; 2021 Mar; 7(10):. PubMed ID: 33674303
[TBL] [Abstract][Full Text] [Related]
23. High-Plex Assessment of Biomarkers in Tumors.
Aung TN; Bates KM; Rimm DL
Mod Pathol; 2024 Mar; 37(3):100425. PubMed ID: 38219953
[TBL] [Abstract][Full Text] [Related]
24. Unsupervised Stain Decomposition via Inversion Regulation for Multiplex Immunohistochemistry Images.
Abousamra S; Fassler D; Yao J; Gupta R; Kurc T; Escobar-Hoyos L; Samaras D; Shroyer K; Saltz J; Chen C
Proc Mach Learn Res; 2023 Jul; 227():74-94. PubMed ID: 38817539
[TBL] [Abstract][Full Text] [Related]
25. An Interactive Pipeline for Quantitative Histopathological Analysis of Spatially Defined Drug Effects in Tumors.
Ahn SW; Ferland B; Jonas OH
J Pathol Inform; 2021; 12():34. PubMed ID: 34760331
[TBL] [Abstract][Full Text] [Related]
26. Computational multiplex panel reduction to maximize information retention in breast cancer tissue microarrays.
Ternes L; Lin JR; Chen YA; Gray JW; Chang YH
PLoS Comput Biol; 2022 Sep; 18(9):e1010505. PubMed ID: 36178966
[TBL] [Abstract][Full Text] [Related]
27. Fiber-Type Shifting in Sarcopenia of Old Age: Proteomic Profiling of the Contractile Apparatus of Skeletal Muscles.
Dowling P; Gargan S; Swandulla D; Ohlendieck K
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768735
[TBL] [Abstract][Full Text] [Related]
28. Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis.
Huang W; Ran R; Shao B; Li H
Breast Cancer Res Treat; 2019 Nov; 178(1):17-33. PubMed ID: 31359214
[TBL] [Abstract][Full Text] [Related]
29. Emerging measurements for tumor-infiltrating lymphocytes in breast cancer.
Wu R; Horimoto Y; Oshi M; Benesch MGK; Khoury T; Takabe K; Ishikawa T
Jpn J Clin Oncol; 2024 Jun; 54(6):620-629. PubMed ID: 38521965
[TBL] [Abstract][Full Text] [Related]
30. Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer.
Jahangir CA; Page DB; Broeckx G; Gonzalez CA; Burke C; Murphy C; Reis-Filho JS; Ly A; Harms PW; Gupta RR; Vieth M; Hida AI; Kahila M; Kos Z; van Diest PJ; Verbandt S; Thagaard J; Khiroya R; Abduljabbar K; Acosta Haab G; Acs B; Adams S; Almeida JS; Alvarado-Cabrero I; Azmoudeh-Ardalan F; Badve S; Baharun NB; Bellolio ER; Bheemaraju V; Blenman KR; Botinelly Mendonça Fujimoto L; Burgues O; Chardas A; Cheang MCU; Ciompi F; Cooper LA; Coosemans A; Corredor G; Dantas Portela FL; Deman F; Demaria S; Dudgeon SN; Elghazawy M; Fernandez-Martín C; Fineberg S; Fox SB; Giltnane JM; Gnjatic S; Gonzalez-Ericsson PI; Grigoriadis A; Halama N; Hanna MG; Harbhajanka A; Hart SN; Hartman J; Hewitt S; Horlings HM; Husain Z; Irshad S; Janssen EA; Kataoka TR; Kawaguchi K; Khramtsov AI; Kiraz U; Kirtani P; Kodach LL; Korski K; Akturk G; Scott E; Kovács A; Laenkholm AV; Lang-Schwarz C; Larsimont D; Lennerz JK; Lerousseau M; Li X; Madabhushi A; Maley SK; Manur Narasimhamurthy V; Marks DK; McDonald ES; Mehrotra R; Michiels S; Kharidehal D; Minhas FUAA; Mittal S; Moore DA; Mushtaq S; Nighat H; Papathomas T; Penault-Llorca F; Perera RD; Pinard CJ; Pinto-Cardenas JC; Pruneri G; Pusztai L; Rajpoot NM; Rapoport BL; Rau TT; Ribeiro JM; Rimm D; Vincent-Salomon A; Saltz J; Sayed S; Hytopoulos E; Mahon S; Siziopikou KP; Sotiriou C; Stenzinger A; Sughayer MA; Sur D; Symmans F; Tanaka S; Taxter T; Tejpar S; Teuwen J; Thompson EA; Tramm T; Tran WT; van der Laak J; Verghese GE; Viale G; Wahab N; Walter T; Waumans Y; Wen HY; Yang W; Yuan Y; Bartlett J; Loibl S; Denkert C; Savas P; Loi S; Specht Stovgaard E; Salgado R; Gallagher WM; Rahman A
J Pathol; 2024 Mar; 262(3):271-288. PubMed ID: 38230434
[TBL] [Abstract][Full Text] [Related]
31. Multiplex immunohistochemistry and high-throughput image analysis for evaluation of spatial tumor immune cell markers in human breast cancer.
Su T; Wang S; Huang S; Cai H; McKinley ET; Beeghly-Fadiel A; Zheng W; Shu XO; Cai Q
Cancer Biomark; 2022; 35(2):193-206. PubMed ID: 36093688
[TBL] [Abstract][Full Text] [Related]
32. Developing an enhanced 7-color multiplex IHC protocol to dissect immune infiltration in human cancers.
Sun Z; Nyberg R; Wu Y; Bernard B; Redmond WL
PLoS One; 2021; 16(2):e0247238. PubMed ID: 33596250
[TBL] [Abstract][Full Text] [Related]
33. Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy.
Dieci MV; Tsvetkova V; Griguolo G; Miglietta F; Tasca G; Giorgi CA; Cumerlato E; Massa D; Lo Mele M; Orvieto E; Guarneri V; Conte P
Eur J Cancer; 2020 Sep; 136():7-15. PubMed ID: 32622323
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?
Koletsa T; Kotoula V; Koliou GA; Manousou K; Chrisafi S; Zagouri F; Sotiropoulou M; Pentheroudakis G; Papoudou-Bai A; Christodoulou C; Xepapadakis G; Zografos G; Petraki K; Pazarli E; Koutras A; Kourea HP; Bafaloukos D; Chatzopoulos K; Iliadis A; Markopoulos C; Venizelos V; Arnogiannaki N; Kalogeras KT; Kostopoulos I; Gogas H; Fountzilas G
Cancer Immunol Immunother; 2020 Aug; 69(8):1549-1564. PubMed ID: 32303794
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of PD-L1, tumor-infiltrating lymphocytes, and CD8+ and FOXP3+ immune cells in HER2-positive breast cancer treated with neoadjuvant therapies.
Zhao J; Meisel J; Guo Y; Nahta R; Hsieh KL; Peng L; Wei Z; O'Regan R; Li X
Breast Cancer Res Treat; 2020 Oct; 183(3):599-606. PubMed ID: 32715443
[TBL] [Abstract][Full Text] [Related]
36. Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer.
Sugie T; Sato E; Miyashita M; Yamaguchi R; Sakatani T; Kozuka Y; Moritani S; Suzuki E; Kakimi K; Mikami Y; Moriya T
Breast Cancer; 2020 Jul; 27(4):519-526. PubMed ID: 32447649
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
